Dr. Hu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Pierce Ave
Nashville, TN 37232Phone+1 615-936-2000
Education & Training
Massachusetts General HospitalPost-Doctoral Fellowship, 1999 - 2005
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1998 - 2001
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
New York University School of MedicineClass of 1995
Harvard UniversityA.B., Biology, cum laude, 1981 - 1985
Certifications & Licensure
TN State Medical License 2016 - 2027
MI State Medical License 2005 - 2018
MA State Medical License 1998 - 2007
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2011
Publications & Presentations
PubMed
- 2 citationsIs it time to reduce the length of postgraduate training for physician-scientists in internal medicine?Emily Jane Gallagher, Paul R Conlin, Barbara I Kazmierczak, Jatin M Vyas, Olujimi A Ajijola
JCI Insight. 2024-05-22 - 1 citationsStructural insights into the career path between pre- and postgraduate physician-scientist training programs.Christopher S Williams, Emily J Gallagher, Don C Rockey, Olujimi A Ajijola, Patrick J Hu
Elife. 2023-10-02 - 4 citationsPearls of wisdom for aspiring physician-scientist residency applicants and program directors.Emily J Gallagher, Don C Rockey, Christopher D Kontos, Jatin M Vyas, Lawrence F Brass
JCI Insight. 2022-03-22
Journal Articles
- Insulin/insulin-like growth factor signaling in C. elegansMurphy CT, Hu PJ, Wormbook
Press Mentions
A Common Insulin Signaling Pathway Across Cancer and DiabetesDecember 4th, 2019
Grant Support
- FoxO Phosphorylation in the Control of C. elegans Life SpanNational Institute on Aging2012–Present
- EAK-7, a Novel Regulator of FoxO Tumor SuppressorsAmerican Cancer Society2010–Present
- Genetic Modifiers of In Vivo Hypoxia ResistanceAmerican Heart Association2011–2012
- Novel Regulators Of FOXO Transcription FactorsNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2009
- Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Genetic Analysis Of DAF-18/PTEN Signaling In C.ElegansNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2004
Professional Memberships
- American Society of Clinical InvestigationMember
- Genetics Society of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
